Pemigatinib, an FGFR inhibitor, overcomes resistance to KRASG12C inhibitors in mesenchymal-like NSCLC tumors Margaret Favata,Michael Weber, Angela Abdollahi, Valerie Dostalik Roman, Matt Farren, Aidan Gilmartin, Sunkyu Kim,Susan Wee,Jonathan Rios-DoriaCANCER RESEARCH(2023)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要